Clinical Trials for High Risk Smoldering Myeloma Patients

Clinical Trials for High Risk Smoldering Myeloma Patients

July 5 @ 7:00pm — 8:00pm EDT

Be proactive in your care by learning about what clinical trials are available to you. No matter where you are in the precursor journey, learning about these trials now can help prepare you for what might come in your future. Multiple Myeloma Specialist, Dr. Jeffrey Zonder, will share his experience in high-risk clinical trials and explain their importance in the future of myeloma. 

Schedule & Agenda

July 5 @ 7:00pm — 8:00pm EDT

7:00pm

Audrey Burton-Bethke

Introductions

Audrey welcomes everybody, shares the event agenda, and introduces our featured speaker.

7:05pm

Jeffrey Zonder, M.D.

Presentation

Dr. Zonder shares his experience in high-risk clinical trials and explains their importance in the future of myeloma. 

7:35pm

Audience

Q&A

Ask Dr. Zonder your questions about his presentation and clinical trials for high-risk smoldering myeloma patients.

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the Myeloma Crowd as the Community Manager in 2020 after previously working in the nonprofit field for 4 years as a director of Fundraising and Development. She gradu...

Read Bio

Jeffrey Zonder, M.D.

Dr. Jeffrey Zonder, MD is a Hematology Specialist in Detroit, MI and has over 26 years of experience in the medical field. He graduated from Wayne State University School Of Medic...

Read Bio

Need help? Contact us!

Need help? Contact us!

Call or text us at 800-709-1113 with questions or concerns, and we'll be happy to help!

Register Today!

July 5 @ 7:00pm — 8:00pm EDT


Thanks to our Myeloma Crowd Community sponsors:

.                         .